WEBEX: Updates in CLL from ASH 2019


Dr. Versha Banerji summarizes key data from practice-changing studies in treatment-naïve chronic lymphocytic leukemia (CLL) from the 61st American Society of Hematology (ASH) Meeting in Orlando, Florida, December 7-10, 2019. Dr. Versha Banerji is a Hematologist and Senior Scientist at CancerCare Manitoba. The Webex can be viewed online at any time using this link.

Funded by AstraZeneca and developed through IMPACT Medicom Inc.

Photo credit: CancerCare Manitoba Foundation